Tasly Pharmaceutical Group Co., Ltd (TASLY PHARMACEUTICAL GROUP CO L) aksje
600535.SS
Forsinket 15 minTASLY PHARMACEUTICAL GROUP CO L
Market Cap
$21,438,181,376
Om Tasly Pharmaceutical Group Co., Ltd (TASLY PHARMACEUTICAL GROUP CO L) aksje
Tasly Pharmaceutical Group Co., Ltd, together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers prescription drugs covering various therapeutic areas, including cardiovascular-cerebrovascular, tumor immunity, digestion and metabolism, and neuroscience; over-the-counter drugs; modern TCM; biological drugs; and chemical drugs. It also engages in medical instruments, agriculture, and chain drugstore activities. The company was formerly known as Tianjin Tasly Pharmaceutical Co., Ltd. and changed its name to Tasly Pharmaceutical Group Co., Ltd in May 2012. Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is headquartered in Tianjin, China.
Selskapsinformasjon
300410 Tianjin, China
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.